Cargando…

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer

PURPOSE: To evaluate guideline adherence and variation in the recommended use of neoadjuvant chemotherapy (NAC) and the effects of this variation on survival in patients with non-metastatic muscle-invasive bladder cancer (MIBC). PATIENTS AND METHODS: In this nationwide, Netherlands Cancer Registry-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hoogstraten, Lisa M. C., Man, Calvin C. O., Witjes, J. Alfred, Meijer, Richard P., Mulder, Sasja F., Smilde, Tineke J., Ripping, Theodora M., Kiemeney, Lambertus A., Aben, Katja K. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231297/ https://www.ncbi.nlm.nih.gov/pubmed/37258902 http://dx.doi.org/10.1007/s00345-023-04443-7

Ejemplares similares

Non‐metastatic muscle‐invasive bladder cancer: the role of age in receiving treatment with curative intent
por: van Hoogstraten, Lisa M.C., et al.
Publicado: (2022)

Adherence to the WCRF/AICR Cancer Prevention Recommendations and Risk of Recurrence in Non-muscle Invasive Bladder Cancer
por: van Zutphen, Moniek, et al.
Publicado: (2022)

Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB)
por: Ripping, T. M., et al.
Publicado: (2020)

Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
por: Ripping, Theodora M., et al.
Publicado: (2021)

Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?
por: Nuijens, Siberyn T., et al.
Publicado: (2023)

Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer
por: Richters, Anke, et al.
Publicado: (2021)

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer
por: Ripping, T. M., et al.
Publicado: (2022)

The prognostic value of family history among patients with urinary bladder cancer
por: Egbers, Lieke, et al.
Publicado: (2015)

The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life
por: de Goeij, Liesbeth, et al.
Publicado: (2019)

Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response
por: Grotenhuis, Anne J., et al.
Publicado: (2016)

Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417 patients
por: van Hoogstraten, L. M. C., et al.
Publicado: (2021)

The present and future burden of urinary bladder cancer in the world
por: Ploeg, Martine, et al.
Publicado: (2009)

Prognostic Relevance of Urinary Bladder Cancer Susceptibility Loci
por: Grotenhuis, Anne J., et al.
Publicado: (2014)

The global burden of urinary bladder cancer: an update
por: Richters, Anke, et al.
Publicado: (2019)

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
por: van Zutphen, Moniek, et al.
Publicado: (2023)

The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer
por: Walraven, Janneke E.W., et al.
Publicado: (2022)

Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands
por: Deukeren, Désirée van, et al.
Publicado: (2022)

Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI
por: Richters, Anke, et al.
Publicado: (2021)

Identification of long non-coding RNAs that stimulate cell survival in bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2017)

No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
por: Evers, Jelle, et al.
Publicado: (2020)

LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2018)

Smoking intensity and bladder cancer aggressiveness at diagnosis
por: Barbosa, André L. A., et al.
Publicado: (2018)

Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis
por: Beeren, Ivy, et al.
Publicado: (2022)

Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis
por: Westhoff, Ellen, et al.
Publicado: (2018)

Personal hair dye use and the risk of bladder cancer: a case–control study from The Netherlands
por: Ros, Martine M., et al.
Publicado: (2012)

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
por: van Puffelen, Jelmer H, et al.
Publicado: (2023)

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy
por: Somford, Diederik M., et al.
Publicado: (2011)

Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer
por: Kok, Dieuwertje E. G., et al.
Publicado: (2010)

Follow-up in non-muscle invasive bladder cancer: facts and future
por: Witjes, J. Alfred
Publicado: (2020)

The association of body composition with postoperative complications and length of hospital stay after radical or partial nephrectomy in patients with renal cell cancer: a multicenter population-based cohort study
por: Maurits, Jake S. F., et al.
Publicado: (2022)

The relationship between sunitinib exposure and both efficacy and toxicity in real‐world patients with renal cell carcinoma and gastrointestinal stromal tumour
por: Westerdijk, Kim, et al.
Publicado: (2020)

Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness
por: van Roermund, Joep G. H., et al.
Publicado: (2009)

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
por: Kiemeney, L. A., et al.
Publicado: (1993)

Experimental rat bladder urothelial cell carcinoma models
por: Arentsen, Harm C., et al.
Publicado: (2009)

Cohort profile – the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands
por: Maurits, Jake S F, et al.
Publicado: (2023)

Urine cell-based DNA methylation classifier for monitoring bladder cancer
por: van der Heijden, Antoine G., et al.
Publicado: (2018)

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
por: Witjes, J Alfred, et al.
Publicado: (2021)

Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma in Situ of the Urinary Bladder: A Retrospective Multicentre Study
por: van Valenberg, F. Johannes P., et al.
Publicado: (2018)

Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival
por: van Dijk, P. R., et al.
Publicado: (2011)

Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study
por: Aben, Katja K. H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uu12llo86m5rbfskctl8862k2e